SAM #DARPA-SN-26-77

DARPA Special Notice: Future Program - Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID)

This Special Notice from DARPA's Biological Technologies Office (BTO) announces the upcoming Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. - Issued by the Defense Advanced Research Projects Agency (DARPA), Biological Technologies Office - Focuses on future research in resuscitation and prevention of ischemia-induced dysfunction - No specific products, part numbers, or vendors are identified at this stage - No quantities or technical requirements are provided in this notice - This is a pre-solicitation announcement; a formal solicitation will be posted on SAM.gov in the future - Interested parties should monitor for the forthcoming solicitation for detailed requirements and submission instructions - The contracting office is located at 675 North Randolph Street, Arlington, VA

Description

The purpose of this Special Notice (SN) is to provide public notification of additional research areas of interest to the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO), specifically for the forthcoming Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program.When released, the solicitation will be made available at https://sam.gov/

View original listing